Cleared Traditional

K963327 - TIDAL WAVE CARBON DIOXIDE MONITOR

K963327 is an FDA 510(k) clearance for TIDAL WAVE CARBON DIOXIDE MONITOR, manufactured by Novametrix Medical Systems, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K963327 · Novametrix Medical Systems, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1996
Decision
89d
Days
Class 2
Risk

K963327 is an FDA 510(k) clearance for the TIDAL WAVE CARBON DIOXIDE MONITOR, MODEL 610. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Novametrix Medical Systems, Inc. (Wallingford, US). The FDA issued a Cleared decision on November 20, 1996 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Novametrix Medical Systems, Inc. devices

FDA 510(k) Submission Details - K963327

510(k) Number K963327 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 1996
Decision Date November 20, 1996
Days to Decision 89 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 140d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 154
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K963327.
FUKUDA DENSHI MODEL HC-500 END TIDAL CO2 MODULE
K980979 · Fukuda Denshi USA, Inc. · Jun 1998
MODEL 405T WITH ETCO2 OPTION
K964961 · Ivy Biomedical Systems, Inc. · May 1997
NIHON KOHDEN OLG-100A POCKETCAP POCKET CO2 MONITOR WITH ACCESSORIES
K964305 · Nihon Kohden America, Inc. · Feb 1997
DISPOSABLE GAS SAMPLING INTERFACE KITS
K960972 · Marquest Medical Products, Inc. · Oct 1996
SIEMENS SC 9000 ETCO2 MODULE
K954632 · Siemens Medical Solutions USA, Inc. · Feb 1996
FUKUDA DENSHI MODEL HC-300 END TIDAL CO2 MODULE
K950044 · Fukuda Denshi USA, Inc. · Sep 1995